We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Spectral Diagnostics Inc., and Toray Medical Co.,Ltd. today announced the launch of a combined diagnostic and therapeutic strategic alliance for the management of severe sepsis.
CardiacAssist, Inc., announced today that its TandemHeart PTVA System percutaneous ventricular assist device (VAD) technology will be included in five presentations at the American Society for Artificial Internal Organs' (ASAIO) 52nd Annual Conference in Chicago from June 8-10.
Shares of medical-device maker Cyberonics Inc. tumbled in Thursday morning trading after an analyst said past stock options granted to executives showed "unusual activity."
American Medical Systems Holdings Inc. said Thursday its $715 million acquisition of Laserscope Inc. will cut into its 2007 net earnings per share, but add to earnings starting in 2008.
Atherotech has contracted with Source Scientific, LLC, a medical device developer and manufacturer, to create a line of cholesterol diagnostics and to modularize VAP Test equipment for placement with a broad array of domestic and international diagnostic laboratories, the companies reported.
Differences in the regulations for device trials as opposed to those for drugs can lead clinical sites into trouble if they do not understand those differences, said officials at a company currently conducting two Phase III investigational device exemption (IDE) trials.
Between 8 and 12 million Americans are affected by peripheral arterial disease, or PAD, where the arteries that bring blood to the legs are blocked by atherosclerotic plaque.
Advanced Cell Technology, Inc. will participate at the European Stem Cells & Regenerative Medicine Congress 2006, June 5-7, at Jumeirah Carlton Tower, London, United Kingdom. Michael D. West, Ph.D., Chairman, President and Chief Scientific Officer, is scheduled to take part in a panel discussion titled Realizing Therapeutic Potential, on Wednesday, June 7th.